James M. Mock - 04 Apr 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Financial Officer
Signature: /s/ James Dillon, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 04 Apr 2025
Net transactions value: -$18,088
Form type: 4
Filing time: 07 Apr 2025, 16:18:17 UTC
Previous filing: 03 Mar 2025
Next filing: 29 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+1,452	+9.8%		16,326	04 Apr 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$18,088	-703	-4.3%	$25.73	15,623	04 Apr 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-1,452	-14%	$0.000000	8,717	04 Apr 2025	Common Stock	1,452		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units.
F3	25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.